Moxibustion for Mild and Moderate Ulcerative Colitis
Launched by SHANGHAI INSTITUTE OF ACUPUNCTURE, MOXIBUSTION AND MERIDIAN · Mar 9, 2014
Trial Information
Current as of June 25, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Meet the diagnosis of UC
- • Mayo ≤10
- • Patients should have never received any pharmacological therapy or if they are receiving aminosalicylates and/or prednisolone (the dosage has been taken at least 4 weeks, and should be kept the same as before throughout the trial)
- • Patients should have never received antibiotic, biologicals, probiotics, acetaminophen, acetamide and contraceptive.
- • A written informed consent
- Exclusion Criteria:
- • Patients with cardiac, encephalic, hepatic, nephric, hematopoietic system, psychotic or any other serious diseases
- • Pregnancy or lactation
About Shanghai Institute Of Acupuncture, Moxibustion And Meridian
The Shanghai Institute of Acupuncture, Moxibustion and Meridian is a leading research organization dedicated to advancing the field of traditional Chinese medicine through rigorous scientific inquiry. With a strong focus on acupuncture and moxibustion techniques, the institute aims to explore and validate the efficacy and mechanisms of these therapies in various clinical settings. Committed to fostering innovation and excellence, the institute collaborates with healthcare professionals and academic institutions to conduct clinical trials and promote evidence-based practices. Through its work, the Shanghai Institute strives to enhance patient care and contribute to the global understanding of integrative medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shanghai, , China
Patients applied
Trial Officials
Huangan Wu, Doctor
Study Director
Shanghai Institute of Acupuncture-Moxibustion and Meridian, Shanghai University of Traditional Chinese Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials